Arrowhead Pharmaceuticals Inc (ARWR)
24.44
+0.31
(+1.28%)
USD |
NASDAQ |
May 03, 16:00
24.44
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash from Operations (TTM): -196.21M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -196.21M |
| September 30, 2023 | -153.89M |
| June 30, 2023 | -197.37M |
| March 31, 2023 | -244.74M |
| December 31, 2022 | -150.34M |
| September 30, 2022 | -136.13M |
| June 30, 2022 | -91.42M |
| March 31, 2022 | -52.22M |
| December 31, 2021 | 148.93M |
| September 30, 2021 | 171.31M |
| June 30, 2021 | 184.08M |
| March 31, 2021 | 180.26M |
| December 31, 2020 | -111.19M |
| September 30, 2020 | -95.80M |
| June 30, 2020 | -70.73M |
| March 31, 2020 | -26.78M |
| December 31, 2019 | -18.78M |
| September 30, 2019 | 173.04M |
| June 30, 2019 | 156.54M |
| March 31, 2019 | 131.61M |
| December 31, 2018 | 135.75M |
| September 30, 2018 | -47.22M |
| June 30, 2018 | -53.75M |
| March 31, 2018 | -49.75M |
| December 31, 2017 | -48.63M |
| Date | Value |
|---|---|
| September 30, 2017 | -23.94M |
| June 30, 2017 | -24.92M |
| March 31, 2017 | -32.86M |
| December 31, 2016 | -33.28M |
| September 30, 2016 | -64.43M |
| June 30, 2016 | -66.27M |
| March 31, 2016 | -61.03M |
| December 31, 2015 | -62.66M |
| September 30, 2015 | -65.71M |
| June 30, 2015 | -64.61M |
| March 31, 2015 | -61.27M |
| December 31, 2014 | -52.59M |
| September 30, 2014 | -35.42M |
| June 30, 2014 | -29.89M |
| March 31, 2014 | -25.45M |
| December 31, 2013 | -22.22M |
| September 30, 2013 | -19.03M |
| June 30, 2013 | -18.23M |
| March 31, 2013 | -16.78M |
| December 31, 2012 | -16.47M |
| September 30, 2012 | -15.34M |
| June 30, 2012 | -12.42M |
| March 31, 2012 | -9.551M |
| December 31, 2011 | -6.673M |
| September 30, 2011 | -5.391M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-244.74M
Minimum
Mar 2023
184.08M
Maximum
Jun 2021
-27.97M
Average
-70.73M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -324.23M |
| Viking Therapeutics Inc | -54.87M |
| Akero Therapeutics Inc | -145.37M |
| 89bio Inc | -129.19M |
| Sagimet Biosciences Inc | -23.77M |